HHS Issues Notice of Enforcement Discretion for COVID-19 Community-Based Testing Sites

The Department of Health and Human Services’ Office for Civil Rights (OCR) has issued a Notice of Enforcement Discretion covering the good faith operation of COVID-19 community-based testing sites by HIPAA-covered entities and their business associates.

OCR will not be issuing HIPAA penalties to covered entities and business associates that participate in the testing and collection of samples at COVID-19 community-based testing sites, such as mobile walk-up testing facilities and drive-through testing sites for the duration of the COVID-19 public health emergency. The Notice of Enforcement Discretion has been backdated to March 13, 2020.

While enforcement discretion will be exercised by OCR, HIPAA-covered entities and their business associates should still implement safeguards at COVID-19 community-based testing sites to protect individuals’ privacy and safeguards should be implemented to ensure protected health information is secured at rest and in transit.

To ensure patient privacy, OCR recommends erecting screens, barriers, and canopies at the testing sites to make it difficult for other users and the public to view people being tested. Filming should be prohibited at the sites and signs erected advising users that the use of cameras and other recording equipment is banned.

Social distancing measures should be implemented to protect the public. OCR recommends a distance of at least 6 feet should be maintained between users of the facility. This will also help to ensure that any communications between patients and healthcare employees remain private and cannot be overheard.

A Notice of Privacy Practices (NPP) should be clearly visible to users of the facility and a copy of the NPP should be posted online. The printed NPP should provide the necessary information to allow visitors to the facility to find the online notice.


Simple Guidelines
Immediate PDF Download

Immediate Access

Privacy Policy

Aside from when PHI is required for the purpose of providing treatment, all other uses and disclosures of PHI should be limited to the minimum necessary amount to achieve the purpose for which the PHI is being used or disclosed.

About Liam Johnson
Liam Johnson has produced articles about HIPAA for several years. He has extensive experience in healthcare privacy and security. With a deep understanding of the complex legal and regulatory landscape surrounding patient data protection, Liam has dedicated his career to helping organizations navigate the intricacies of HIPAA compliance. Liam focusses on the challenges faced by healthcare providers, insurance companies, and business associates in complying with HIPAA regulations. Liam has been published in leading healthcare publications, including The HIPAA Journal. Liam was appointed Editor-in-Chief of The HIPAA Guide in 2023. Contact Liam via LinkedIn: https://www.linkedin.com/in/liamhipaa/